Largest health care pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 health care pharmaceutical companies ranked by net assets, at ZAR 1.5T, ahead of Johnson & Johnson (ZAR 1.41T) and Sanofi (ZAR 1.37T). Figures as of 19 Nov 2026, 14:53 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerZAR 1.5T
- Median
- ZAR 15.2B
- Combined market value
- ZAR 86.39T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | ZAR 1.5T | ZAR 2.73T | ZAR 478.39 | 1.49% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | ZAR 1.41T | ZAR 11.11T | ZAR 4,615.63 | 2.20% down | 34% up | ||
| 3 | SanofiSNY · Health Care | ZAR 1.37T | ZAR 1.91T | ZAR 797.51 | 2.21% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | ZAR 910.5B | ZAR 5.76T | ZAR 2,338.36 | 1.94% down | 45% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | ZAR 902.2B | ZAR 3.14T | ZAR 1,812.92 | 0.25% up | 16% down | ||
| 6 | AstraZenecaAZN · Health Care | ZAR 842.3B | ZAR 4.73T | ZAR 3,049.51 | 1.43% down | 1% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | ZAR 805.3B | ZAR 1.19T | ZAR 371.06 | 0.78% up | 51% up | ||
| 8 | NovartisNVS · Health Care | ZAR 798.4B | ZAR 4.95T | ZAR 2,620.47 | 2.48% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 541B | ZAR 1.67T | ZAR 16,140.68 | 1.37% down | 28% up | ||
| 10 | Novo NordiskNVO · Health Care | ZAR 498.4B | ZAR 2.99T | ZAR 679.22 | 0.52% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | ZAR 459.2B | ZAR 21.08T | ZAR 23,660.00 | 1.13% down | 33% up | ||
| 12 | GSKGSK · Health Care | ZAR 376.2B | ZAR 1.66T | ZAR 830.39 | 1.24% down | 5% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 323.1B | ZAR 2.33T | ZAR 9,172.76 | 1.20% down | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | ZAR 319.7B | ZAR 2.07T | ZAR 1,011.43 | 1.88% down | 30% up | ||
| 15 | ViatrisVTRS · Health Care | ZAR 254.6B | ZAR 397.8B | ZAR 347.01 | 1.13% down | 99% up | ||
| 16 | Royalty PharmaRPRX · Health Care | ZAR 168.1B | ZAR 679.5B | ZAR 1,181.73 | 0.57% down | 79% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 136.9B | ZAR 820.9B | ZAR 703.53 | 3.68% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | ZAR 122.8B | ZAR 421.8B | ZAR 9,903.72 | 0.88% down | 22% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | ZAR 113.3B | ZAR 232.4B | ZAR 465.04 | 0.64% up | 26% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 105.3B | ZAR 211.2B | ZAR 1,090.52 | 2.57% up | 17% up | ||
| 21 | GrifolsGRFS · Health Care | ZAR 101.2B | ZAR 97.9B | ZAR 143.82 | 1.89% down | 0% up | ||
| 22 | GenmabGMAB · Health Care | ZAR 101.2B | ZAR 551.8B | ZAR 894.95 | 1.45% up | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | ZAR 78.4B | ZAR 489.3B | ZAR 675.32 | 0.75% up | 91% up | ||
| 24 | BeOne MedicinesONC · Health Care | ZAR 75.5B | ZAR 795.8B | ZAR 6,967.14 | 0.26% down | 16% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 74.7B | ZAR 270B | ZAR 4,207.01 | 1.89% down | 41% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 69.4B | ZAR 214.4B | ZAR 257.18 | 0.80% down | 8% up | ||
| 27 | ZoetisZTS · Health Care | ZAR 57.6B | ZAR 585.8B | ZAR 1,441.82 | 2.64% down | 26% down | ||
| 28 | AlkermesALKS · Health Care | ZAR 31.5B | ZAR 133.9B | ZAR 796.82 | 1.73% down | 66% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | ZAR 17.6B | ZAR 102.9B | ZAR 5,142.89 | 0.52% down | 50% up | ||
| 30 | Legend BiotechLEGN · Health Care | ZAR 17.3B | ZAR 53.7B | ZAR 276.91 | 1.54% down | 41% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | ZAR 15.2B | ZAR 153.7B | ZAR 5,499.33 | 4.12% up | 86% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 13.7B | ZAR 345.3B | ZAR 2,577.89 | 0.30% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | ZAR 13.3B | ZAR 108B | ZAR 2,658.54 | 1.68% down | 43% up | ||
| 34 | InsmedINSM · Health Care | ZAR 12.8B | ZAR 458.6B | ZAR 2,090.44 | 0.82% up | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | ZAR 12.4B | ZAR 165.3B | ZAR 1,740.23 | 0.90% down | 332% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | ZAR 11.4B | ZAR 144.9B | ZAR 181.21 | 0.29% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | ZAR 11.2B | ZAR 173.1B | ZAR 1,145.31 | 0.08% up | 117% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | ZAR 11.2B | ZAR 127.4B | ZAR 1,164.25 | 0.77% down | 10% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | ZAR 11B | ZAR 84B | ZAR 482.87 | 0.32% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | ZAR 10.6B | ZAR 143.7B | ZAR 2,202.15 | 0.06% up | 51% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 10.4B | ZAR 160.3B | ZAR 6,901.46 | 0.17% up | 27% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 9.8B | ZAR 129.5B | ZAR 1,648.07 | 0.18% up | 129% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | ZAR 9B | ZAR 78.1B | ZAR 713.74 | 0.31% down | 86% up | ||
| 44 | ABIVAXABVX · Health Care | ZAR 8.7B | ZAR 128.1B | ZAR 1,463.66 | 0.88% up | 32% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | ZAR 8.5B | ZAR 83.5B | ZAR 1,482.70 | 2.01% up | 108% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | ZAR 8.5B | ZAR 78.5B | ZAR 471.45 | 0.55% down | 63% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | ZAR 8.2B | ZAR 115.4B | ZAR 1,701.29 | 2.67% up | 255% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 8.1B | ZAR 105.3B | ZAR 744.72 | 0.19% down | 13% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | ZAR 5.8B | ZAR 69.4B | ZAR 506.92 | 0.58% up | 168% up | ||
| 50 | ErascaERAS · Health Care | ZAR 5.6B | ZAR 85.2B | ZAR 242.82 | 1.96% up | 395% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 5.4B | ZAR 104.3B | ZAR 1,597.79 | 0.18% down | 34% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 2.4B | ZAR 141.1B | ZAR 2,034.45 | 1.25% down | 18% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | ZAR 2B | ZAR 83.8B | ZAR 872.54 | 0.35% up | 45% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | ZAR 1.5B | ZAR 122.3B | ZAR 2,324.60 | 0.24% up | 6% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -ZAR 1.2B | ZAR 129.9B | ZAR 372.79 | 1.55% down | 90% up | ||
| 56 | VeradermicsMANE · Health Care | -ZAR 2.1B | ZAR 91.8B | ZAR 2,175.85 | 0.66% up | 231% up | ||
| 57 | Ascendis PharmaASND · Health Care | -ZAR 3.1B | ZAR 306.8B | ZAR 4,677.59 | 0.02% down | 29% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -ZAR 3.6B | ZAR 86.1B | ZAR 1,030.46 | 1.15% down | 21% down | ||
| 59 | CytokineticsCYTK · Health Care | -ZAR 11.4B | ZAR 124.8B | ZAR 895.81 | 0.86% up | 19% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -ZAR 36.1B | ZAR 267.9B | ZAR 1,375.22 | 1.86% up | 21% up | ||
| 61 | AbbVieABBV · Health Care | -ZAR 56.6B | ZAR 8.61T | ZAR 4,872.81 | 1.54% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.3071 ZAR).
Questions and answers
Which health care pharmaceutical companies rank first by net assets?
Pfizer (ZAR 1.5T), Johnson & Johnson (ZAR 1.41T) and Sanofi (ZAR 1.37T) are the top three of the 61 health care pharmaceutical companies ranked by net assets as of 19 Nov 2026, 14:53 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by net assets have a combined market value of ZAR 86.39T as of 19 Nov 2026, 14:53 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.